Depreciation in USD of MYRIAD GENETICS INC from 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
MYRIAD GENETICS INC quarterly/annual Depreciation history and change rate from 2010 to Q3 2025.
  • MYRIAD GENETICS INC Depreciation for the quarter ending 30 Sep 2025 was $4.8M, unchanged year-over-year.
  • MYRIAD GENETICS INC Depreciation for the twelve months ending 30 Sep 2025 was $20M, a 7.53% increase year-over-year.
  • MYRIAD GENETICS INC annual Depreciation for 2024 was $19.5M, a 2.09% increase from 2023.
  • MYRIAD GENETICS INC annual Depreciation for 2023 was $19.1M, a 64.7% increase from 2022.
  • MYRIAD GENETICS INC annual Depreciation for 2022 was $11.6M, a 4.13% decline from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

MYRIAD GENETICS INC Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $20M $4.8M $0 0% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025
Q2 2025 $20M $4.9M +$300K +6.52% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 $19.7M $5.1M +$200K +4.08% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025
Q4 2024 $19.5M $5.2M +$900K +20.9% 01 Oct 2024 31 Dec 2024 10-K 28 Feb 2025
Q3 2024 $18.6M $4.8M +$1.4M +41.2% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025
Q2 2024 $17.2M $4.6M +$1.9M +70.4% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025
Q1 2024 $15.3M $4.9M -$3.8M -43.7% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025
Q4 2023 $19.1M $4.3M +$1.2M +38.7% 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2025
Q3 2023 $17.9M $3.4M +$500K +17.2% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024
Q2 2023 $17.4M $2.7M -$100K -3.57% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024
Q1 2023 $17.5M $8.7M +$5.9M +211% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024
Q4 2022 $11.6M $3.1M -$100K -3.13% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2025
Q3 2022 $11.7M $2.9M +$300K +11.5% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023
Q2 2022 $11.4M $2.8M -$600K -17.6% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023
Q1 2022 $12M $2.8M -$100K -3.45% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023
Q4 2021 $12.1M $3.2M 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2024
Q3 2021 $2.6M +$200K +8.33% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022
Q2 2021 $3.4M +$900K +36% 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2022
Q1 2021 $2.9M +$300K +11.5% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022
Q3 2020 $10.5M $2.4M -$500K -17.2% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2020 $11M $2.5M -$600K -19.4% 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021
Q1 2020 $11.6M $2.6M -$500K -16.1% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021
Q4 2019 $12.1M $3M +$400K +15.4% 01 Oct 2019 31 Dec 2019 10-Q 07 Feb 2020
Q3 2019 $11.7M $2.9M -$2M -40.8% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 $13.7M $3.1M -$2.7M -46.6% 01 Apr 2019 30 Jun 2019 10-K 25 Feb 2022
Q1 2019 $16.4M $3.1M -$500K -13.9% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020
Q4 2018 $16.9M $2.6M -$1.2M -31.6% 01 Oct 2018 31 Dec 2018 10-Q 07 Feb 2020
Q3 2018 $18.1M $4.9M +$1M +25.6% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019
Q2 2018 $17.1M $5.8M +$1.8M +45% 01 Apr 2018 30 Jun 2018 10-KT 16 Mar 2021
Q1 2018 $15.3M $3.6M -$100K -2.7% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019
Q4 2017 $15.4M $3.8M +$200K +5.56% 01 Oct 2017 31 Dec 2017 10-Q 06 Feb 2019
Q3 2017 $15.2M $3.9M +$200K +5.41% 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018
Q2 2017 $15M $4M +$600K +17.6% 01 Apr 2017 30 Jun 2017 10-K 13 Aug 2019
Q1 2017 $14.4M $3.7M +$200K +5.71% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018
Q4 2016 $14.2M $3.6M $0 0% 01 Oct 2016 31 Dec 2016 10-Q 07 Feb 2018
Q3 2016 $14.2M $3.7M +$100K +2.78% 01 Jul 2016 30 Sep 2016 10-Q 08 Nov 2017
Q2 2016 $14.1M $3.4M -$100K -2.86% 01 Apr 2016 30 Jun 2016 10-K 24 Aug 2018
Q1 2016 $14.2M $3.5M +$200K +6.06% 01 Jan 2016 31 Mar 2016 10-Q 03 May 2017
Q4 2015 $14M $3.6M +$700K +24.1% 01 Oct 2015 31 Dec 2015 10-Q 08 Feb 2017
Q3 2015 $13.3M $3.6M +$1M +38.5% 01 Jul 2015 30 Sep 2015 10-Q 02 Nov 2016
Q2 2015 $12.3M $3.5M 01 Apr 2015 30 Jun 2015 10-K 09 Aug 2017
Q1 2015 $3.3M 01 Jan 2015 31 Mar 2015 10-Q 04 May 2016
Q4 2014 $2.9M 01 Oct 2014 31 Dec 2014 10-Q 03 Feb 2016
Q3 2014 $2.6M 01 Jul 2014 30 Sep 2014 10-Q 04 Nov 2015

MYRIAD GENETICS INC Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $19.5M +$400K +2.09% 01 Jan 2024 31 Dec 2024 10-K 28 Feb 2025
2023 $19.1M +$7.5M +64.7% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2025
2022 $11.6M -$500K -4.13% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025
2021 $12.1M +$1.1M +10% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024
2020 $11M -$2.7M -19.7% 01 Jul 2019 30 Jun 2020 10-K 01 Mar 2023
2019 $13.7M -$3.4M -19.9% 01 Jul 2018 30 Jun 2019 10-K 25 Feb 2022
2018 $17.1M +$2.1M +14% 01 Jul 2017 30 Jun 2018 10-KT 16 Mar 2021
2017 $15M +$900K +6.38% 01 Jul 2016 30 Jun 2017 10-K 13 Aug 2019
2016 $14.1M +$1.8M +14.6% 01 Jul 2015 30 Jun 2016 10-K 24 Aug 2018
2015 $12.3M +$3.1M +33.7% 01 Jul 2014 30 Jun 2015 10-K 09 Aug 2017
2014 $9.2M +$1.2M +15% 01 Jul 2013 30 Jun 2014 10-K 10 Aug 2016
2013 $8M +$31K +0.39% 01 Jul 2012 30 Jun 2013 10-K 12 Aug 2015
2012 $7.97M +$1.14M +16.6% 01 Jul 2011 30 Jun 2012 10-K 13 Aug 2014
2011 $6.83M +$72K +1.07% 01 Jul 2010 30 Jun 2011 10-K 14 Aug 2013
2010 $6.76M 01 Jul 2009 30 Jun 2010 10-K 15 Aug 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.